ASX - Delayed Quote AUD

Vita Life Sciences Limited (VLS.AX)

Compare
1.8500
0.0000
(0.00%)
At close: April 4 at 10:40:43 AM GMT+11
Loading Chart for VLS.AX
  • Previous Close 1.8500
  • Open 1.8970
  • Bid 1.8750 x --
  • Ask 1.9450 x --
  • Day's Range 1.8500 - 1.8970
  • 52 Week Range 1.6200 - 2.4600
  • Volume 66,568
  • Avg. Volume 21,903
  • Market Cap (intraday) 102.606M
  • Beta (5Y Monthly) 0.48
  • PE Ratio (TTM) 11.56
  • EPS (TTM) 0.1600
  • Earnings Date Feb 24, 2025
  • Forward Dividend & Yield 0.10 (5.41%)
  • Ex-Dividend Date Mar 21, 2025
  • 1y Target Est --

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritionals; urinary health; weight management; immunity; skin, hair, and nails; liver and digestion; fertility, pregnancy, and postpartum; blood sugar management; cardiovascular health; pain and inflammation; men, women, and children's health; antioxidants; bones, joints, and muscles; and eye health. The company markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia.

vitalifesciences.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VLS.AX

View More

Performance Overview: VLS.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

VLS.AX
4.28%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

VLS.AX
15.49%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

VLS.AX
11.83%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

VLS.AX
260.54%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: VLS.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VLS.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    102.61M

  • Enterprise Value

    74.52M

  • Trailing P/E

    11.72

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.29

  • Price/Book (mrq)

    1.96

  • Enterprise Value/Revenue

    0.94

  • Enterprise Value/EBITDA

    5.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.05%

  • Return on Assets (ttm)

    11.06%

  • Return on Equity (ttm)

    18.36%

  • Revenue (ttm)

    79.5M

  • Net Income Avi to Common (ttm)

    8.78M

  • Diluted EPS (ttm)

    0.1600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    28.6M

  • Total Debt/Equity (mrq)

    0.99%

  • Levered Free Cash Flow (ttm)

    4.43M

Research Analysis: VLS.AX

View More

Company Insights: VLS.AX

Research Reports: VLS.AX

View More

People Also Watch